nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—White blood cell count increased—Metformin—polycystic ovary syndrome	0.0896	0.159	CcSEcCtD
Lomitapide—Reaction gastrointestinal—Metformin—polycystic ovary syndrome	0.0539	0.0956	CcSEcCtD
Lomitapide—MTTP—embryo—polycystic ovary syndrome	0.0498	0.322	CbGeAlD
Lomitapide—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.0342	0.0607	CcSEcCtD
Lomitapide—MTTP—female gonad—polycystic ovary syndrome	0.0275	0.177	CbGeAlD
Lomitapide—MTTP—endocrine gland—polycystic ovary syndrome	0.0255	0.165	CbGeAlD
Lomitapide—MTTP—Circadian rythm related genes—SFTPC—polycystic ovary syndrome	0.021	0.0747	CbGpPWpGaD
Lomitapide—CYP3A4—urine—polycystic ovary syndrome	0.0192	0.124	CbGeAlD
Lomitapide—Nasal congestion—Metformin—polycystic ovary syndrome	0.0143	0.0254	CcSEcCtD
Lomitapide—Pain in extremity—Metformin—polycystic ovary syndrome	0.0131	0.0232	CcSEcCtD
Lomitapide—Migraine—Metformin—polycystic ovary syndrome	0.0128	0.0228	CcSEcCtD
Lomitapide—Dehydration—Metformin—polycystic ovary syndrome	0.0121	0.0215	CcSEcCtD
Lomitapide—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.012	0.0214	CcSEcCtD
Lomitapide—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.0119	0.0211	CcSEcCtD
Lomitapide—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0117	0.0207	CcSEcCtD
Lomitapide—Abdominal distension—Metformin—polycystic ovary syndrome	0.0114	0.0201	CcSEcCtD
Lomitapide—Influenza—Metformin—polycystic ovary syndrome	0.0113	0.02	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—CLDN4—polycystic ovary syndrome	0.011	0.0392	CbGpPWpGaD
Lomitapide—Angina pectoris—Metformin—polycystic ovary syndrome	0.011	0.0195	CcSEcCtD
Lomitapide—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0108	0.0192	CcSEcCtD
Lomitapide—Infestation NOS—Metformin—polycystic ovary syndrome	0.0101	0.0178	CcSEcCtD
Lomitapide—Infestation—Metformin—polycystic ovary syndrome	0.0101	0.0178	CcSEcCtD
Lomitapide—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00951	0.0169	CcSEcCtD
Lomitapide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.00932	0.0331	CbGpPWpGaD
Lomitapide—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00887	0.0157	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—STAR—polycystic ovary syndrome	0.00873	0.031	CbGpPWpGaD
Lomitapide—Eye disorder—Metformin—polycystic ovary syndrome	0.00844	0.015	CcSEcCtD
Lomitapide—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00838	0.0149	CcSEcCtD
Lomitapide—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00814	0.0144	CcSEcCtD
Lomitapide—Chills—Metformin—polycystic ovary syndrome	0.0081	0.0144	CcSEcCtD
Lomitapide—Malnutrition—Metformin—polycystic ovary syndrome	0.00786	0.0139	CcSEcCtD
Lomitapide—Flatulence—Metformin—polycystic ovary syndrome	0.00775	0.0137	CcSEcCtD
Lomitapide—ABCB1—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.00774	0.0275	CbGpPWpGaD
Lomitapide—Muscle spasms—Metformin—polycystic ovary syndrome	0.00756	0.0134	CcSEcCtD
Lomitapide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00729	0.0129	CcSEcCtD
Lomitapide—Malaise—Metformin—polycystic ovary syndrome	0.00709	0.0126	CcSEcCtD
Lomitapide—Palpitations—Metformin—polycystic ovary syndrome	0.00695	0.0123	CcSEcCtD
Lomitapide—Myalgia—Metformin—polycystic ovary syndrome	0.00669	0.0119	CcSEcCtD
Lomitapide—Chest pain—Metformin—polycystic ovary syndrome	0.00669	0.0119	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00665	0.0118	CcSEcCtD
Lomitapide—Discomfort—Metformin—polycystic ovary syndrome	0.00661	0.0117	CcSEcCtD
Lomitapide—Infection—Metformin—polycystic ovary syndrome	0.00637	0.0113	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00634	0.0225	CbGpPWpGaD
Lomitapide—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00629	0.0112	CcSEcCtD
Lomitapide—Skin disorder—Metformin—polycystic ovary syndrome	0.00623	0.0111	CcSEcCtD
Lomitapide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.0062	0.011	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.00605	0.0215	CbGpPWpGaD
Lomitapide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00584	0.0104	CcSEcCtD
Lomitapide—Paraesthesia—Metformin—polycystic ovary syndrome	0.00576	0.0102	CcSEcCtD
Lomitapide—Somnolence—Metformin—polycystic ovary syndrome	0.0057	0.0101	CcSEcCtD
Lomitapide—Dyspepsia—Metformin—polycystic ovary syndrome	0.00565	0.01	CcSEcCtD
Lomitapide—Decreased appetite—Metformin—polycystic ovary syndrome	0.00558	0.00989	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00554	0.00982	CcSEcCtD
Lomitapide—Fatigue—Metformin—polycystic ovary syndrome	0.00553	0.00981	CcSEcCtD
Lomitapide—Constipation—Metformin—polycystic ovary syndrome	0.00549	0.00973	CcSEcCtD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—polycystic ovary syndrome	0.00539	0.0192	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.00529	0.0188	CbGpPWpGaD
Lomitapide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00529	0.00938	CcSEcCtD
Lomitapide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00525	0.00931	CcSEcCtD
Lomitapide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.00518	0.0184	CbGpPWpGaD
Lomitapide—Abdominal pain—Metformin—polycystic ovary syndrome	0.00507	0.009	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00501	0.0178	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00501	0.0178	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—TOP2A—polycystic ovary syndrome	0.00481	0.0171	CbGpPWpGaD
Lomitapide—ABCB1—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.00465	0.0165	CbGpPWpGaD
Lomitapide—Asthenia—Metformin—polycystic ovary syndrome	0.0046	0.00817	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.00447	0.0159	CbGpPWpGaD
Lomitapide—ABCB1—embryo—polycystic ovary syndrome	0.0044	0.0284	CbGeAlD
Lomitapide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00439	0.00779	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.00433	0.0154	CbGpPWpGaD
Lomitapide—Dizziness—Metformin—polycystic ovary syndrome	0.00424	0.00753	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—TH—polycystic ovary syndrome	0.0042	0.0149	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.0042	0.0149	CbGpPWpGaD
Lomitapide—Vomiting—Metformin—polycystic ovary syndrome	0.00408	0.00724	CcSEcCtD
Lomitapide—Headache—Metformin—polycystic ovary syndrome	0.00402	0.00713	CcSEcCtD
Lomitapide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.00399	0.0142	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00398	0.0141	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.00393	0.014	CbGpPWpGaD
Lomitapide—Nausea—Metformin—polycystic ovary syndrome	0.00381	0.00676	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.0038	0.0135	CbGpPWpGaD
Lomitapide—ABCB1—adrenal cortex—polycystic ovary syndrome	0.0036	0.0233	CbGeAlD
Lomitapide—MTTP—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.00327	0.0116	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00323	0.0115	CbGpPWpGaD
Lomitapide—ABCB1—endometrium—polycystic ovary syndrome	0.00322	0.0208	CbGeAlD
Lomitapide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00319	0.0206	CbGeAlD
Lomitapide—MTTP—Metabolism—NMNAT3—polycystic ovary syndrome	0.00309	0.011	CbGpPWpGaD
Lomitapide—ABCB1—uterus—polycystic ovary syndrome	0.00296	0.0191	CbGeAlD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00294	0.0105	CbGpPWpGaD
Lomitapide—ABCB1—pituitary gland—polycystic ovary syndrome	0.00291	0.0188	CbGeAlD
Lomitapide—ABCB1—adipose tissue—polycystic ovary syndrome	0.0029	0.0187	CbGeAlD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00288	0.0102	CbGpPWpGaD
Lomitapide—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.00287	0.0102	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—LPCAT2—polycystic ovary syndrome	0.00282	0.01	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—SUOX—polycystic ovary syndrome	0.00282	0.01	CbGpPWpGaD
Lomitapide—ABCB1—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00281	0.00997	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00279	0.0099	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.00269	0.00955	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ISYNA1—polycystic ovary syndrome	0.00262	0.00932	CbGpPWpGaD
Lomitapide—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.00262	0.00932	CbGpPWpGaD
Lomitapide—ABCB1—adrenal gland—polycystic ovary syndrome	0.0026	0.0168	CbGeAlD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00256	0.00911	CbGpPWpGaD
Lomitapide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.00251	0.0089	CbGpPWpGaD
Lomitapide—ABCB1—female gonad—polycystic ovary syndrome	0.00242	0.0157	CbGeAlD
Lomitapide—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00242	0.0086	CbGpPWpGaD
Lomitapide—ABCB1—vagina—polycystic ovary syndrome	0.00241	0.0156	CbGeAlD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00239	0.00851	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.00234	0.00832	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00227	0.00807	CbGpPWpGaD
Lomitapide—ABCB1—endocrine gland—polycystic ovary syndrome	0.00225	0.0146	CbGeAlD
Lomitapide—MTTP—Metabolism—TEAD2—polycystic ovary syndrome	0.00223	0.00793	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—AKR1C2—polycystic ovary syndrome	0.00223	0.00793	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00215	0.00762	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00211	0.0075	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.00211	0.00749	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PNPLA2—polycystic ovary syndrome	0.00187	0.00664	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB1—polycystic ovary syndrome	0.00184	0.00653	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—SRD5A1—polycystic ovary syndrome	0.00177	0.0063	CbGpPWpGaD
Lomitapide—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00173	0.00614	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—STAR—polycystic ovary syndrome	0.00169	0.00601	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00167	0.00594	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—polycystic ovary syndrome	0.00161	0.00573	CbGpPWpGaD
Lomitapide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00158	0.00562	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—HMMR—polycystic ovary syndrome	0.00151	0.00535	CbGpPWpGaD
Lomitapide—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00144	0.00511	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—HSD3B1—polycystic ovary syndrome	0.00144	0.00511	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00142	0.00505	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—FOXP3—polycystic ovary syndrome	0.00141	0.00501	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00135	0.00479	CbGpPWpGaD
Lomitapide—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00132	0.0047	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—LHB—polycystic ovary syndrome	0.00131	0.00466	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—TFRC—polycystic ovary syndrome	0.00128	0.00455	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—HSD3B2—polycystic ovary syndrome	0.00128	0.00455	CbGpPWpGaD
Lomitapide—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00127	0.00452	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—AKR1C1—polycystic ovary syndrome	0.00124	0.00441	CbGpPWpGaD
Lomitapide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.00122	0.00434	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—SULT2A1—polycystic ovary syndrome	0.00114	0.00406	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—RRM2—polycystic ovary syndrome	0.00111	0.00393	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—YAP1—polycystic ovary syndrome	0.00107	0.00379	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00106	0.00377	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NAMPT—polycystic ovary syndrome	0.00102	0.00364	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.00102	0.00362	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP11A1—polycystic ovary syndrome	0.00101	0.00359	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.001	0.00357	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.001	0.00357	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—AKR1C3—polycystic ovary syndrome	0.000956	0.00339	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP17A1—polycystic ovary syndrome	0.000941	0.00334	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000926	0.00329	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000914	0.00325	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000867	0.00308	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000861	0.00306	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00085	0.00302	CbGpPWpGaD
Lomitapide—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000843	0.00299	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—TH—polycystic ovary syndrome	0.000814	0.00289	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000809	0.00287	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—SLC2A4—polycystic ovary syndrome	0.000792	0.00281	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00079	0.00281	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000751	0.00267	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP19A1—polycystic ovary syndrome	0.000744	0.00264	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	0.000717	0.00255	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000698	0.00248	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000681	0.00242	CbGpPWpGaD
Lomitapide—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000679	0.00241	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000672	0.00239	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GNAS—polycystic ovary syndrome	0.000664	0.00236	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000654	0.00232	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NCOR1—polycystic ovary syndrome	0.000633	0.00225	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP1A1—polycystic ovary syndrome	0.0006	0.00213	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000576	0.00205	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.000563	0.002	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—MTHFR—polycystic ovary syndrome	0.000559	0.00199	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000552	0.00196	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000549	0.00195	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000548	0.00195	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000542	0.00193	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000521	0.00185	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000482	0.00171	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PPARG—polycystic ovary syndrome	0.000454	0.00161	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00045	0.0016	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—POMC—polycystic ovary syndrome	0.000447	0.00159	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000445	0.00158	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—INS—polycystic ovary syndrome	0.000445	0.00158	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000444	0.00158	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000426	0.00151	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000409	0.00145	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000399	0.00142	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000393	0.0014	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.000387	0.00137	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000371	0.00132	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000371	0.00132	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000366	0.0013	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000363	0.00129	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000338	0.0012	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	0.000335	0.00119	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000332	0.00118	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000309	0.0011	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	0.000309	0.0011	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000293	0.00104	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000289	0.00103	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000287	0.00102	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000253	0.000899	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000244	0.000867	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000244	0.000867	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000237	0.00084	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000233	0.000829	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000221	0.000785	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000218	0.000773	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000208	0.000739	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000205	0.000727	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000202	0.000718	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000194	0.000689	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.00019	0.000676	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.00019	0.000676	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—STAR—polycystic ovary syndrome	0.000185	0.000657	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000185	0.000657	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000177	0.000628	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000176	0.000626	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000165	0.000588	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	0.000165	0.000586	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000157	0.000559	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000155	0.000551	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.00015	0.000534	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.00015	0.000534	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LHB—polycystic ovary syndrome	0.000143	0.00051	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.00014	0.000498	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000136	0.000482	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000126	0.000448	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000125	0.000444	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	0.000121	0.00043	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000119	0.000425	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	0.000117	0.000415	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000114	0.000405	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	0.000112	0.000398	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000111	0.000393	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000105	0.000371	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000103	0.000366	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000102	0.000361	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	9.69e-05	0.000344	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—TH—polycystic ovary syndrome	8.9e-05	0.000316	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.84e-05	0.000314	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	8.66e-05	0.000308	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	8.64e-05	0.000307	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	8.37e-05	0.000297	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	8.14e-05	0.000289	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.7e-05	0.000274	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	7.46e-05	0.000265	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	7.27e-05	0.000258	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.19e-05	0.000255	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	6.92e-05	0.000246	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.91e-05	0.000245	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.82e-05	0.000242	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	6.56e-05	0.000233	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.44e-05	0.000229	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.34e-05	0.000225	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	6.12e-05	0.000217	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.49e-05	0.000195	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.34e-05	0.00019	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.02e-05	0.000178	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.96e-05	0.000176	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.89e-05	0.000174	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.87e-05	0.000173	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.48e-05	0.000159	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.27e-05	0.000152	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.04e-05	0.000144	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.77e-05	0.000134	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.06e-05	0.000109	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.02e-05	0.000107	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3e-05	0.000107	CbGpPWpGaD
